Atalaya Capital Management’s FinTech Evolution Acquisition Group Units, each consisting of one Class A Ordinary Share, and one-third of one redeemable warrant FTEV.U Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-50,000
Closed -$494K 382
2021
Q1
$494K Buy
+50,000
New +$499K 0.1% 132

Other funds holding FTEV.U

Atalaya Capital Management's FTEV.U Position: Q2 2021 in Review

Atalaya Capital Management sold out of FinTech Evolution Acquisition Group Units, each consisting of one Class A Ordinary Share, and one-third of one redeemable warrant (FTEV.U) in Q2 2021, closing a stake of 50,000 shares — an estimated $494K sold.

Atalaya Capital Management first reported a position in FTEV.U in Q1 2021 and held it in 1 quarter. The position peaked at $494K in Q1 2021. 56 funds tracked by Wall St. Rank hold FTEV.U as of Q2 2021.

  • Atalaya Capital Management reported no remaining FinTech Evolution Acquisition Group Units, each consisting of one Class A Ordinary Share, and one-third of one redeemable warrant position as of Q2 2021 after selling out during the quarter.
  • Atalaya Capital Management sold 50,000 FinTech Evolution Acquisition Group Units, each consisting of one Class A Ordinary Share, and one-third of one redeemable warrant shares in Q2 2021, an estimated $494K.
  • Atalaya Capital Management first reported a position in FinTech Evolution Acquisition Group Units, each consisting of one Class A Ordinary Share, and one-third of one redeemable warrant in Q1 2021 and held it in 1 quarter.
  • Atalaya Capital Management's FinTech Evolution Acquisition Group Units, each consisting of one Class A Ordinary Share, and one-third of one redeemable warrant position peaked at $494K in Q1 2021.
  • 56 funds tracked by Wall St. Rank held FinTech Evolution Acquisition Group Units, each consisting of one Class A Ordinary Share, and one-third of one redeemable warrant as of Q2 2021.

Based on Atalaya Capital Management's 13F filing for Q2 2021, filed 12 Aug 2021.